Nilotinib Hcl
Brand name: Tasigna
Rank #155 of 500 drugs by total cost
$100.9M
Total Cost
6,308
Total Claims
$100.9M
Total Cost
393
Prescribers
$16K
Cost per Claim
11
Beneficiaries
6,373
30-Day Fills
$257K
Avg Cost/Provider
16
Avg Claims/Provider
About Nilotinib Hcl
Nilotinib Hcl (sold as Tasigna) was prescribed 6,308 times by 393 Medicare Part D providers in 2023, costing the program $100.9M. At $16K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 152 | Relugolix (Orgovyx) | $107.3M | 38,821 |
| 153 | Pen Needle, Diabetic (Ultra-Fine Mini Pen Needle) | $105.0M | 1,305,150 |
| 154 | Divalproex Sodium (Divalproex Sodium) | $103.4M | 1,921,840 |
| 155 | Nilotinib Hcl (Tasigna) | $100.9M | 6,308 |
| 156 | Quetiapine Fumarate (Quetiapine Fumarate) | $100.9M | 3,820,737 |
| 157 | Ubrogepant (Ubrelvy) | $100.6M | 75,781 |
| 158 | Darunavir/Cobicistat (Prezcobix) | $99.7M | 38,374 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology